Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Search
  1. OncologyPRO
  2. Meeting resources
  3. ESMO 2016

Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Conclusions and clinical perspectives

Date

10 Oct 2016

Session

Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Presenters

Felix Feng

Authors

F. Feng

Author affiliations

  • Radiation Oncology, University of Michigan, 48109-5010 - Ann Arbor/US
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: David Olmos

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Webcast

What is the role of CTCs?

Presenter: Howard Scher

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings